FindTrial
Sign In

Uncovering Metabolomic Markers for Renal Tranplant Outcomes

Metabolomics Evaluation in Patients Post Renal Transplantation - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073494
Enrollment
50
Registered
2024-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z940- Kidney transplant status

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients above the age of 18 diagnosed with CKD are approved to receive kidney transplants and are willing to participate.

Exclusion criteria

Exclusion criteria: Patients not receiving transplant at Kasturba Hospital.

Design outcomes

Primary

MeasureTime frame
Change in urine metabolite levels pre and post transplantTimepoint: 4 months—

Secondary

MeasureTime frame
Change in urine metabolite levels in pre transplant and Acute Tubular NecrosisTimepoint: 4 months;Change in urine metabolite levels in pre transplant and Transplant RejectionTimepoint: 4 months—

Countries

India

Contacts

Public ContactDr Shankar Prasad N

Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal

mohan.vb@manipal.edu9902548725

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026